Skip to content
lifestyle.wordsjournal.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Yatiri Bio
Yatiri Bio Enters Exclusive Option to In-License Agreement with Oscotec for Denfivontinib in AML
March 24, 2026
Yatiri Bio Accurately Predicts AML Drug Response in Blinded Study Using Foghorn’s FHD-286
February 11, 2026